Related Experiment Video
Updated: Sep 19, 2025

Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Published on: March 3, 2016
SOX10, MITF, and microRNAs: Decoding their interplay in regulating melanoma plasticity
Xin Lai1,2,3, Chunyan Luan3, Zhesi Zhang1
1Biomedicine Unit, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Abstract:
Recent studies show that the dysregulation of the transcription factor SOX10 is essential for the development and progression of melanoma. MicroRNAs (miRNAs) can regulate the expression of transcription factors at the post-transcriptional level. The interactions between SOX10 and its targeting miRNAs form network motifs such as feedforward and feedback loops. Such motifs can result in nonlinear dynamics in gene expression levels, therefore playing a crucial role in regulating tumor proliferation and metastasis as well as the tumor's responses to therapies. Here, we reviewed and discussed the intricate interplay between SOX10 and miRNAs in melanoma biology including melanogenesis, phenotype switch, and therapy resistance. Additionally, we investigated the gene regulatory interactions in melanoma, identifying crucial network motifs that involve SOX10, MITF, and miRNAs. We also analyzed the expression levels of the components within these motifs. From a control theory perspective, we explained how these dynamics are linked to the phenotypic plasticity of melanoma cells. In summary, we underscored the importance of employing a data-driven network biology approach to elucidate the complex regulatory mechanisms and identify driver network motifs within the melanoma network. This methodology facilitates a deeper understanding of the regulation of SOX10 and MITF by miRNAs in melanoma. The insight gained could potentially contribute to the development of miRNA-based treatments, thereby enhancing the clinical management of this malignancy.
Related Concept Videos
MicroRNAs
Induced Pluripotent Stem Cells
Somatic...
Pleiotropy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

